Search results
Results from the WOW.Com Content Network
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
In 1999, IBM withdrew as a part owner of IBA, while remaining its major business partner. In 2000, the IBA IT GmbH office opened in Düsseldorf, Germany. [7] In 2005, the head office of IBA Group was opened in Prague and at the same time IBA CZ office expanded to include a branch in Brno, Czech Republic. [8] In 2010, an office was opened in Astana.
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off .
Pages in category "Pharmaceutical companies of Thailand" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes .
Location of Indonesia. Indonesia is a unitary sovereign state and transcontinental country located mainly in Southeast Asia with some territories in Oceania. Indonesia's economy is the world's 16th largest by nominal GDP and the 8th largest by GDP at PPP, the largest in Southeast Asia, and is considered an emerging market and newly industrialised country.
[1]: 55 Besides Thailand, it markets its products in Nigeria, Ghana, Bhutan, Somalia, Myanmar, Sri Lanka, Malaysia, Cambodia, and Vietnam. [3] The GPO gives Thailand significant leverage in its price negotiations with foreign drug suppliers. [4] [5] As of 2018, GPO's chairman is Dr Sopon Mekthon, [6] who took over from Dr Nopporn Cheanklin. [7]
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. [1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.